NR 546 Final PRACTICE EXAM Psychopharmacology EXAM QUESTIONS AND VERIFIED ANSWERS| GRADE A| 100% CORRECT (2024/ 2025 UPDATE)
NR 546 Final PRACTICE EXAM Psychopharmacology EXAM QUESTIONS AND VERIFIED ANSWERS| GRADE A| 100% CORRECT (2024/ 2025 UPDATE) MAOIs (monoamine oxidase inhibitors) affect which neurotransmitters? A. Serotonin, Dopamine, Norepinephrine B. Serotonin, GABA, Glutamate C. Acetylcholine, Dopamine, Norepinephrine D. Dopamine, GABA, Acetylcholine A. Serotonin, Dopamine, Norepinephrine Which of the following is considered first line treatment for depression? A. SSRI B. FGA C. SNRI D. MAOI A. SSRI When treating a patient for major depression disorder which medication would the PMHNP consider first? A. Depakote B. Selegiline C. Escitalopram D. Isocarboxazid C. Escitalopram Which of the following medication should be considered for a patient diagnosed with major depressive disorder who reports "always forgetting to take my pills"? A. Mirtazapine B. Fluvoxamine C. Fluoxetine D. Carbemazepine C. Fluoxetine Which of the following medication has a black box warning of a life-threatening skin rash?
Written for
- Institution
-
Chamberlain College Of Nursing
- Course
-
NR 546 / NR546
Document information
- Uploaded on
- May 24, 2024
- Number of pages
- 24
- Written in
- 2023/2024
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
nr 546 final practice exam psychopharmacology exam
-
nr 546 final practice exam psychopharmacology ex
Also available in package deal